Latest news with #Miller-Meeks'
Yahoo
2 days ago
- Business
- Yahoo
Protesters wait outside Rep. Miller-Meeks' event in Davenport
There were contrasting emotions in and around Rhythm City Casino Thursday morning. Congressman Jim Jordan, R.-Ohio, joined congresswoman Mariannette Miller-Meeks and her supporters for a reception and discussed president Trump's recent 'One Big Beautiful Bill,' a piece of legislation that passed through the House of Representatives. 'We just want to make sure she wins, and she is going to. She is a great candidate, but we are here just to help,' Jordan said.'There are provisions in (the One Big Beautiful Bill) for every Iowan and every American, and there are provisions that strengthen and preserve Medicaid,' Miller-Meeks said. Outside of Rhythm City, however, some of Miller-Meeks' constituents were not happy. 'Care about your voters, care about people who aren't voters,' said Tracy Jones, one of the protesters. '(Miller-Meeks) doesn't want to be held under the microscope for her terrible decisions, and it's wrong. Protesters were upset with Rep. Miller-Meeks for not holding a townhall meeting and supporting trump's One Big Beautiful Bill, which includes significant cuts to Medicaid and SNAP. 'Who would vote to take food from children? That's not a good person,' Jones said. 'When you are in Congress, you are supposed to be the voice of the people that put you there, and they deserve to have answers on what you are doing,' said Travis Terrell, a Democratic candidate for Rep. Miller-Meeks' 1st Congressional District seat. Rep. Miller-Meeks, though, feels as if she is doing just that. 'We are absolutely voting in (the constituents') best interest because we voted to preserve and strengthen Medicaid,' Miller-Meeks said. 'Had we not done that, the trajectory of Medicaid spending is unsustainable.' Protesters, however, said they wanted more transparency. 'If you are scared to be transparent with your constituents, it's because you know you betrayed them,' Terrell said. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
28-04-2025
- Politics
- Yahoo
Iowa rep in swing district endorsed by group working to elect GOP women
A Republican congresswoman from Iowa in a swing district has picked up an endorsement from a group working to elect more GOP women. Rep. Mariannette Miller-Meeks, R-Iowa, was among a group of candidates in the House and Senate to receive first-round 2026 endorsements by Winning for Women PAC, which works to support free-market conservative women running for federal office. Cook Political Report – the leading nonpartisan handicapper – rates Miller-Meeks' district as a "Toss Up" in 2026. Miller-Meeks won her 2024 re-election bid in November after a recount confirmed her lead, helping her party pad its thin majority in the U.S. House and retain control of all four of Iowa's congressional seats. She defeated Democrat Christina Bohannan in a rematch of 2022, when Miller-Meeks won by 7 percentage points. The 2024 margin was much tighter – Miller-Meeks' lead over Bohannan was less than a percentage point, or fewer than 1,000 votes, according to the Associated Press. Senate Republican Doge Leader Joni Ernst Faces First Democratic Challenger In 2026 Race Miller-Meeks earned a first term in Congress representing Iowa's 2nd District when she defeated Democrat Rita Hart by just six votes in 2020. She currently represents the 1st District, which includes the eastern part of the state and a swath of south-central Iowa, including Johnson County, home to the University of Iowa in Iowa City. Read On The Fox News App Winning for Women PAC on Monday also endorsed Reps. Young Kim R-Calif., and Jen Kiggans, R-Va., in the House, as well as Sens. Ashley Moody, R-Fla., Joni Ernst, R-Iowa, and Susan Collins, R-Maine, in the upper chamber. Kim and Kiggans' districts both "Lean Republican" in 2026, according to Cook Political Report. Moody and Ernst are both in "Solid R" seats, while Collins' district "Leans R" in the 2026 contest. White House Displays Lawn Signs Highlighting Illegal Immigrant Crime "Early financial support is critical, particularly in close races," Danielle Barrow, the president of the Winning for Women PAC, said in a statement obtained by The Hill. "Given Republicans' narrow control of Congress, we are announcing our initial endorsements earlier than ever before to ensure we hold and expand our majorities. We look forward to endorsing more strong women leaders in Congress in the coming weeks." The House currently has 31 Republican women members, while the Senate has just 10. Winning for Women PAC has spent more than $20 million since 2020 on boosting Republican female candidates in competitive primaries and general elections. The Associated Press contributed to this article source: Iowa rep in swing district endorsed by group working to elect GOP women
Fox News
28-04-2025
- Politics
- Fox News
Iowa rep in swing district endorsed by group working to elect GOP women
A Republican congresswoman from Iowa in a swing district has picked up an endorsement from a group working to elect more GOP women. Rep. Mariannette Miller-Meeks, R-Iowa, was among a group of candidates in the House and Senate to receive first-round 2026 endorsements by Winning for Women PAC, which works to support free-market conservative women running for federal office. Cook Political Report – the leading nonpartisan handicapper – rates Miller-Meeks' district as a "Toss Up" in 2026. Miller-Meeks won her 2024 re-election bid in November after a recount confirmed her lead, helping her party pad its thin majority in the U.S. House and retain control of all four of Iowa's congressional seats. She defeated Democrat Christina Bohannan in a rematch of 2022, when Miller-Meeks won by 7 percentage points. The 2024 margin was much tighter – Miller-Meeks' lead over Bohannan was less than a percentage point, or fewer than 1,000 votes, according to the Associated Press. Miller-Meeks earned a first term in Congress representing Iowa's 2nd District when she defeated Democrat Rita Hart by just six votes in 2020. She currently represents the 1st District, which includes the eastern part of the state and a swath of south-central Iowa, including Johnson County, home to the University of Iowa in Iowa City. Winning for Women PAC on Monday also endorsed Reps. Young Kim R-Calif., and Jen Kiggans, R-Va., in the House, as well as Sens. Ashley Moody, R-Fla., Joni Ernst, R-Iowa, and Susan Collins, R-Maine, in the upper chamber. Kim and Kiggans' districts both "Lean Republican" in 2026, according to Cook Political Report. Moody and Ernst are both in "Solid R" seats, while Collins' district "Leans R" in the 2026 contest. "Early financial support is critical, particularly in close races," Danielle Barrow, the president of the Winning for Women PAC, said in a statement obtained by The Hill. "Given Republicans' narrow control of Congress, we are announcing our initial endorsements earlier than ever before to ensure we hold and expand our majorities. We look forward to endorsing more strong women leaders in Congress in the coming weeks." The House currently has 31 Republican women members, while the Senate has just 10. Winning for Women PAC has spent more than $20 million since 2020 on boosting Republican female candidates in competitive primaries and general elections.
Yahoo
21-03-2025
- Business
- Yahoo
D.C. Dispatch: Miller-Meeks, Grassley introduce bills on drug costs
Members of Iowa's congressional delegation proposed legislation aiming to address high prescription drug prices. (Photo illustration by Clark Kauffman/Iowa Capital Dispatch) Members of Iowa's congressional delegation have introduced legislation they say will help lower drug costs. U.S. Congress has largely not met this week, with most of the attention in national politics centering on President Donald Trump's moves to close the U.S. Department of Education and militarize a part of the U.S.-Mexico border. Still, Iowa's federal legislators introduced several measures this week, including proposals dealing with the cost of pharmaceuticals. Rep. Mariannette Miller-Meeks reintroduced the Delinking Revenue from Unfair Gouging (DRUG) Act Tuesday, a bill focused on pharmacy benefit managers (PBMs), the third-party businesses that negotiate prescription drug prices between drug manufacturers, health insurance companies and pharmacies. The Iowa representative also introduced the measure in 2o24. Miller-Meeks' proposal would require PBMs to charge a flat fee for their service in negotiating prices on a certain drug instead of charging using a percentage of the drug price. The current practice of charging based on a percentage of the drug's costs incentivizes PBMs to promote the use of higher-cost medicines, according to a news release from Miller-Meeks' office, which 'takes money away from patients.' SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'Pharmacy benefit managers (PBMs) have excessive influence over the prices patients pay at the pharmacy counter,' Miller-Meeks said in a statement. 'Local Iowa pharmacies are closing due to greedy PBM practices, impacting proximity and access to medications for Iowans. The DRUG Act will put downward pressure on prescription drug prices and insurance premiums by removing the incentive for PBMs to drive up the list price of medications.' Many pharmacists have called for action to restrict certain business practices by PBMs, which they say are raising drug costs and limiting the ability to fill prescriptions. Iowa state lawmakers are also considering legislation that would place limits on some PBM actions. Miller-Meeks has advocated for Congress to ban certain PBM practices, like 'patient steering,' encouraging or requiring patients to use certain affiliated pharmacies instead of a pharmacy of their choice and 'spread pricing,' where a PBM charges a higher cost for a drug than what is reimbursed to the pharmacy — practices that are also a focus of the Iowa legislation. Charles Crain, managing vice president of policy of the advocacy group the National Association of Manufacturers, praised the legislation as a way to help manufacturing employers provide workers affordable health care coverage. 'PBMs increase health care costs by driving up prescription drug list prices, forcing patients to pay more at the pharmacy counter and making it more difficult for manufacturers to offer affordable health care benefits,' Crain said in a statement. 'Manufacturers commend Rep. Miller-Meeks and her colleagues for re-introducing the DRUG Act, which will rein in PBMs operating in the commercial market by removing their perverse incentive to maximize their own profits at the expense of manufacturers and manufacturing workers.' In the Senate, U.S. Sen. Chuck Grassley co-introduced a bill that would attempt to stop pharmaceutical manufacturers from attempting to shut out competitors by 'product hopping.' 'Product hopping' refers to practices by some pharmaceutical companies to coercively move patients using a branded drug that has an expiring patent to a new patented drug in an effort to stop patients from moving to a generic version of the original product. According to a news release from Grassley, some manufacturers use tactics like destroying the inventory of their old product, raising its price or stating it is unsafe in attempts to discourage people from using the drug. 'Under this practice, it is difficult to switch patients to the cheaper generic when the market protections for the earlier drug expire,' the news release stated. 'This abuse of the patent system forces patients to continue paying high costs for a drug that is substantially similar to their old one for many years to come.' Grassley, alongside Sens. John Cornyn, R-Texas, Richard Blumenthal, D-Connecticut and Dick Durbin, D-Illinois, introduced the 'Drug Competition Enhancement Act' Monday that would make product hopping' an antitrust violation. Companies engaging in this practice could face enforcement action from the Federal Trade Commission, including being brought to court. The Iowa Republican said the bipartisan measure would help bring down drug prices by preventing companies from engaging in anticompetitive practices. 'One of my top priorities in the Senate is reducing the cost of prescription drugs,' Grassley said. 'Our bill will bring much needed transparency to drug pricing by cracking down on product hopping and giving Iowans more access to lower-cost generic drugs.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
